Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of novel survivin-derived CTL epitopes.
Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, thor Straten P, Andersen MH. Reker S, et al. Among authors: svane im. Cancer Biol Ther. 2004 Feb;3(2):173-9. doi: 10.4161/cbt.3.2.611. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726703
Immunogenicity of Bcl-2 in patients with cancer.
Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT. Andersen MH, et al. Among authors: svane im. Blood. 2005 Jan 15;105(2):728-34. doi: 10.1182/blood-2004-07-2548. Epub 2004 Sep 14. Blood. 2005. PMID: 15367432 Free article.
The immunogenicity of the hTERT540-548 peptide in cancer.
Wenandy L, Sørensen RB, Sengeløv L, Svane IM, thor Straten P, Andersen MH. Wenandy L, et al. Among authors: svane im. Clin Cancer Res. 2008 Jan 1;14(1):4-7. doi: 10.1158/1078-0432.CCR-07-4590. Clin Cancer Res. 2008. PMID: 18172245 Review.
Cancer treatment: the combination of vaccination with other therapies.
Andersen MH, Sørensen RB, Schrama D, Svane IM, Becker JC, Thor Straten P. Andersen MH, et al. Among authors: svane im. Cancer Immunol Immunother. 2008 Nov;57(11):1735-43. doi: 10.1007/s00262-008-0480-y. Epub 2008 Feb 20. Cancer Immunol Immunother. 2008. PMID: 18286284 Free PMC article. Review.
RhoC a new target for therapeutic vaccination against metastatic cancer.
Wenandy L, Sørensen RB, Svane IM, Thor Straten P, Andersen MH. Wenandy L, et al. Among authors: svane im. Cancer Immunol Immunother. 2008 Dec;57(12):1871-8. doi: 10.1007/s00262-008-0517-2. Epub 2008 Apr 16. Cancer Immunol Immunother. 2008. PMID: 18415097 Free PMC article.
316 results